Why this status
- 19 Dec 2016: Trial registered, NCT02996721
- 3 Apr 2017: Trial started, NCT02996721
The trials
NCT02996721: A Trial Evaluating Vitamin D Normalization on Major Adverse Cardiovascular-Related Events Among Myocardial Infarction Patients
- State
- Completed
- Phase
- Phase 4
- People
- 634 taking part
- Started
- 3 Apr 2017
- Primary completion
- 30 Mar 2025
- Arms
- Treatment
- Results
- None posted
- 19 Dec 2016: Trial registered
- 3 Apr 2017: Trial started
- 4 Sep 2025: Trial completed
How the status changed
- 19 Nov 2026: First set: Phase 3 trial
About the treatment
Also known as Aquadetrim, Arachitol, Bolus vitamin D3, Calciol, Calcirol, CapsuDar D3 100E, D3-Vigantol, Daily Vitamin D3, Davitamon D, Decara, Decristol, Delsterol, Deparal, Devaron, Devikap, Dry Vitamin D3 100CWS/AM, Duphafral D3 1000, Ekostop D3, FeraCol, Granuvit D3, High-D 2X, Lutavit D, Minisun, Oleovit D3, OsteVit D, Plivit D3, Quintox, Riken D3 Oil 100, Riken D3 Oil 20, Rovimix D3 500, Uvedose, Vi-De3, Videkhol, Vigantol, Vigorsan, Vitamin D3, Vitamin D3 S 50t, Vitamin D3, Cholecalciferol, Vitinc Dan-Dee-3.
Registries searched: ClinicalTrials.gov, through 17 Nov 2026.